CompPair secures new funding to accelerate growth and reinforce commercial execution

CompPair Technologies Ltd. announces the successful closing of its latest fundraising round, aimed at strengthening the company’s sales and operational capabilities to support rapid growth. With a strong and diversified commercial pipeline already secured, this investment marks a turning point in CompPair’s journey: not a question of if the company will grow, but how it will sustainably manage and scale that growth.

Led by existing shareholders and joined by strategic and financial investors, including the venture capital arm of Zürcher Kantonalbank (ZKB), the round reflects strong confidence in CompPair’s positioning as a key industrial player in healable composite materials. The investment will enable the company to execute on upcoming commercial projects, reinforce operational excellence, and convert a full pipeline into long-term value creation.

Yves Becker, Investment Manager at ZKB, highlights the company’s maturity and growth trajectory: “CompPair combines advanced materials science with a clear industrial vision. The company has demonstrated its ability to move from innovation to market traction, and we are pleased to support this next phase of scaling.”

Over past years, CompPair has achieved commercial milestones, transitioning from technology validation to real-world industrial adoption. Strategic collaborations, notably with SHD Composites, Salomon and the Swiss Federal Railways (SBB CFF FFS), have reinforced CompPair’s role as an ingredient brand, embedding HealTech™ solutions into established supply chains. In addition, CompPair has integrated major programs within the aerospace domain, including the European Space Agency.

“This round is about execution,” says Amaël Cohades, CEO and co-founder of CompPair. “We have proven the technology, the market pull is strong, and our pipeline is full. This investment allows us to scale with discipline: strengthening sales, operations and delivery to reach a true inflection point in our growth. CompPair is no longer emerging; it is establishing itself as a reference in healable composites.”

The partnerships secured by CompPair stand as key examples of CompPair’s strategy, bringing HealTech™ solutions to a global customer base and reinforcing the company’s credibility with tier-one manufacturers. Building on this momentum, the funding will enable the company to scale production, reinforce customer support and accelerate market deployment, reaching a decisive turning point in its industrial and commercial journey.

According to Marcel Gatti, Member of the Board of Directors, the fundraising confirms CompPair’s strategic direction: “In recent years, CompPair has built solid foundations technologically and commercially. This financing enables the company to manage growth in a structured way while remaining true to its mission.”

Communication relations & contact details

Emilie Malek | Marketing Manager | emilie@comppair.ch |

CompPair Technologies Ltd. | EPFL Innovation Park Building C | CH-1015 Lausanne contact@comppair.ch | www.comppair.ch |